Evotec AG launched its accelerated drug development service INDiGO(R) to deliver better drug candidates to patients faster and more efficiently than standard industry approaches. INDiGO(R) is a proven development solution that has been successfully executed by Evotec’s recent acquisition of Aptuit for several years, who are market leaders in providing high-value integrated drug discovery and…